Flavobacterium indologenes bacteremia: Clinical and microbiological characteristics

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 550-555

  Hsueh, Po Ren ^b   Hsiue, Tzuen Ren ^a   Wu, Jiunn Jong ^b   Teng, Lee Jene ^b   Ho, Shen Wu ^b   Hsieh, Wei Chuan ^b   Luh, Kwen Tay ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFOPERAZONE; CEFTAZIDIME; MINOCYCLINE; PIPERACILLIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; BILIARY TRACT INFECTION; CLINICAL ARTICLE; FEMALE; FLAVOBACTERIUM; HUMAN; MALE; PNEUMONIA; PRIORITY JOURNAL; PYONEPHROSIS; WOUND INFECTION;

EID: 0029787553     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.550     Document Type: Article

References (24)

1. von Graevenitz A. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:520-32.
2. Pedersen MM, Marso E, Pickett MJ. Nonfermentative bacilli associated with man: III. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol 1970;54:178-92.
3. Siegman-Igra Y, Schwarte D, Soferman G, Konforti N. Flavobacterium group lib bacteremia: report of a case and review of Flavobacterium infections. Med Microbiol Immunol (Berl) 1987;176:103-11.
4. Bonten MJM, van Tiel FH, van der Geest S, Smeets HGW, Stobberingh EE, Gaillard CA. Topical antimicrobial prophylaxis of nosocomial pneumonia in mechanically ventilated patients. Microbiological observations. Infection 1993;21:137-9.
5. Bagley DH Jr, Alexander JC Jr, Gill VJ, Dolin R, Ketcham AS. Late Flavobacterium species meningitis after craniofacial exenteration. Arch Intern Med 1976;136:229-31.
6. Stamm WE, Colella JJ, Andersen RL, Dixon RE. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N Engl J Med 1975;292:1099-102.
7. Yabuuchi E, Kaneko T, Yano I, Moss CW, Miyoshi N. Sphingobacterium gen. nov., Sphingobacterium spiritivorum comb, nov., Sphingobacterium multivorum comb, nov., Sphingobacterium mizutae sp. nov., and Flavobacterium indologenes sp. nov.: glucose-nonfermenting, gram-negative rods in CDC group IIk-2 and IIb. Int J Syst Bacteriol 1983;33:580-98.
8. Holmes B, Owen RJ, Steigerwalt AG, Brenner DJ. Flavobacterium gleum, a new species found in human clinical specimens. Int J Syst Bacteriol 1984;34:21-5.
9. Yabuuchi E, Hashimoto Y, Ezaki T, Ido Y, Takeuchi N. Genotypic and phenotypic differentiation of Flavobacterium indologenes Yabuuchi et al 1983 from Flavobacterium gleum Holmes et al 1984. Microbiol Immunol 1990;34:73-6.
10. Pickett MJ. Methods for identification of flavobacteria. J Clin Microbiol 1989;27:2309-15.
11. Microbial identification system operational manual. Version 4. Newark, Delaware: Microbial ID Inc., 1992.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. NCCLS document M2-A5. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
13. Schreckenberger PC. Update of taxonomy of nonfastidious, glucose-nonfermenting, gram-negative bacilli. Clinical Microbiology Newsletter 1995;17:41-7.
14. Moss CW, Dees SB. Cellular fatty acids of Flavobacterium meningosepticum and Flavobacterium species group IIb. J Clin Microbiol 1978;8:772-4.
15. Niederman MS, Mantovani R, Schoch P, Papas J, Fein AM. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients: the role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989;95:155-61.
16. Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987;135:426-32.
17. Langer M, Mosconi P, Cigada M, Mandelli M, and the intensive care unit group of infection control. Long-term respiratory support and risk of pneumonia in critically ill patients. Am Rev Respir Dis 1989;140:302-5.
18. von Graevenitz A, Grehn M. Susceptibility studies on Flavobacterium IIb. FEMS Microbiol Lett 1977;2:289-92.
19. Aber RC, Wennersten C, Moellering RC Jr. Antimicrobial susceptibility of flavobacteria. Antimicrob Agents Chemother 1978;14:483-7.
20. Strandberg DA, Jorgensen JH, Drutz DJ. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother 1983;24:282-6.
21. Jorgensen JH, Maher LA, Howell AW. Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli. Antimicrob Agents Chemother 1991;35:2410-4.
22. Ratner H. Flavobacterium meningosepticum. Infect control 1984;5:237-9.
23. Sader HS, Jones RN, Pfaller MA. Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis. Clin Infect Dis 1995;21:997-1000.
24. Scully BE, Neu HC. Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J Antimicrob Chemother 1986;18(suppl D):179-85.